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doi:10.1016/j.jmii.2011.12.016Background: A high catheter-related bloodstream infection (CRBSI) rate, in comparison with
that in the National Healthcare Safety Network report, is an important concern in our hospital.
Therefore, evidence-based interventions have been introduced to reduce the rate of CRBSI.
Methods: A surveillance study conducted from March 2008 to May 2010 to observe the reduc-
tion of infection rate after interventions in two intensive care units (ICUs). The major interven-
tion, introduced in November 2009, was the standardization of the process of central venous
catheter (CVC) implantation, including hand hygiene and maximal sterile barrier precautions.
Results: The utilization ratios of CVC changed little during the study. The median CRBSI infec-
tion rates decreased from 1.95 (mean 1.58) infections per 1000 catheter-days at baseline to
0 (mean 1.06) after interventions (p Z 0.310 by the Wilcoxon signed ranks test). The rate of
CRBSI in one ICU showed 0 infections per 1000 catheter-days, which was sustained for 6 months
after interventions.
Conclusion: The reduction of infection rates could be possible by standardizing the CVC
implantation procedure. However, more interventions, such as cleaning the skin with chlorhex-
idine, avoiding the femoral site when possible, and removing unnecessary catheters, should
also be considered to reduce the rate of CRBSI.
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Catheter-related bloodstream infection 371Introduction SurveillanceCatheter-related bloodstream infections (CRBSIs) are
prevalent and often fatal, and incur extra hospital cost.1
According to the National Nosocomial Infections Surveil-
lance (NNIS) system and Centers for Disease Control and
Prevention (CDC) report, the median rate of CRBSI in
intensive care units (ICUs) ranges from 1.8 to 5.2 per 1000
catheter-days.1e3 The National Healthcare Safety Network
(NHSN) report showed that the 50th and 90th percentiles
of mean CRBSI rate in medical ICUs are 1.0 and 4.3 per
1000 catheter-days, respectively.4 The Taiwan Nosocomial
Infections Surveillance System (TNIS) report in 2009 showed
that the 50th and 90th percentiles of mean CRBSI rate in
medical ICUs were 5.8 and 11.2 per 1000 catheter-days in
medical centers, and 3.7 and 8.9 per 1000 catheter-days in
regional hospitals.5 In the Changhua Christian Hospital, we
have monitored the rates of CRBSI since March 2008. Our
surveillance data from March 2008 to October 2009 showed
that the infection rate was high (mean 1.8 per 1000
catheter-days). This is therefore an important issue in our
hospital.
A prospective study supported the use of maximal
sterile barrier precautions and antimicrobial-coated cath-
eters in reducing the risk of CRBSI, and these two inter-
ventions had an independent and significant association
with a decrease in the risk of catheter infections.6 In
addition, several large-scale studies support the observa-
tion that evidence-based interventions can reduce the rate
of CRBSI.1,7,8 The strategies for prevention of CRBSI include
hand washing, using full-barrier precautions, cleaning the
skin with chlorhexidine, catheter site selection (avoiding
the femoral site), and removing unnecessary cathe-
ters.1,4,7e9 We introduced evidence-based interventions to
develop a modified standard procedure of central venous
catheter (CVC) implantation in our hospital to reduce the
rate of CRBSI.
Materials and methods
Hospital setting
Changhua Christian Hospital is a medical center in central
Taiwan with a total of 1700 beds, including 2 medical ICUs.
In total there are 55 ICU beds: 29 in ICU1 and 26 in ICU2
(including 8 coronary care unit beds in ICU2).
Definitions
Infections were categorized using the CDC/NHSN stan-
dard definitions that include laboratory and clinical
criteria.10 The blood and tip cultures were collected
according to clinical criteria, such as sudden onset fever
and insertion site wound infection. The definition of
definite CRBSI is the same microorganism in both blood
and tip cultures. The CVC utilization ratio is calculated as
(number of device-days/number of patient-days)  100%,
and the rate of CRBSI as (number of CRBSIs/number of
device-days)  1000&.Since March 2008 the numbers of patient-days, device-
days, and CRBSIs have been collected monthly from the
infection-control practitioner. A surveillance study was
conducted from March 2008 to May 2010 to observe the
reduction of infection rate after interventions in ICU1
and ICU2. Interventions were introduced in November
2009.
Interventions
The strategies for prevention of catheter-related infec-
tions have been reviewed.1,2,7e9 Four of the five recom-
mendations for prevention of CRBSI are associated with
catheter insertion. Because use of skin antiseptic agent
with chlorhexidine was not yet approved in Taiwan when
the study began, and the catheter site selection (avoiding
the femoral site) should be determined by clinical physi-
cians, a modified standard procedure of CVC implantation
was developed in the hospital. This includes hand hygiene
with chlorhexidine gluconate agent and maximal sterile
barrier precautions (e.g., cap, surgical mask, sterile gown,
sterile gloves, and full body sterile drape, similar to the
drapes used in the operating room).11 When the study
began, 10% povidone-iodine alcoholic solution and 70%
alcohol were used for skin preparation. In addition, the
same antiseptic agents were used for skin disinfection
after catheter insertion and transparent medical dressing
was used to cover catheter insertion sites. Educational
programs were arranged in November 2009 for the staff in
medical ICUs, including attending physicians, chief resi-
dents, and nurse practitioners.
Other interventions were introduced gradually into
the hospital after this study period, such as education
of insertion site selection, skin antiseptic agent with
chlorhexidine, catheter site dressing regimens with chlo-
rhexidine, and bedside ultrasound for the placement of
CVCs.
Stastistical analysis
A paired difference test was used to compare the differ-
ence after intervention, which derived data from December
2008 to May 2009 and December 2009 to May 2010. Because
the CRBSI data followed a nonnormal distribution, the p-
values were based on Wilcoxon signed ranks test. In addi-
tion, Poisson regression model was used to analyze the
relative risk (RR) of the rate of catheter related blood-
stream infection after interventions.
Results
The surveillance data from March 2008 to May 2010 are
summarized in Table 1. The trends of the utilization ratios
of CVC and the rate of CRBSI are shown in Figs. 1 and 2.
The overall median utilization ratios of CVC before
(March 2008 to October 2009) and after (December 2009 to
May 2010) interventions were 56.3% (mean 57.6%) and 57.1%
Table 1 The surveillance data from March 2008 to May 2010
Year Month ICU1 ICU2 Overall
Utilization
ratios(％)
Infection
rates(&)
Utilization
ratios(％)
Infection
rates(&)
Utilization
ratios(％)
Infection
rates(&)
2008 03 81.8 0.0 66.1 0.0 74.3 0.0
04 75.9 6.5 48.3 0.0 62.6 4.1
05 76.7 7.8 52.2 2.5 65.0 5.7
06 63.2 2.0 45.0 3.1 54.6 2.4
07 62.2 1.9 49.7 0.0 56.3 1.1
08 61.9 3.8 47.7 0.0 55.2 2.2
09 61.6 2.0 48.4 0.0 55.2 1.2
10 55.2 2.2 47.5 0.0 51.5 1.2
11 59.7 0.0 51.0 0.0 55.0 0.0
12 63.2 3.7 53.3 2.5 58.5 3.2
2009 01 54.4 2.1 56.4 0.0 55.4 1.1
02 56.8 2.2 63.0 0.0 59.7 1.1
03 56.9 4.2 52.5 0.0 54.9 2.3
04 51.8 0.0 54.4 2.5 52.9 1.1
05 65.4 1.8 58.0 0.0 61.9 1.0
06 55.3 0.0 40.9 0.0 48.6 0.0
07 57.4 4.3 57.2 2.4 57.3 3.4
08 61.0 4.1 54.8 0.0 58.1 2.3
09 64.2 0.0 53.6 2.6 59.2 1.1
10 67.7 1.9 43.7 0.0 56.2 1.2
11a 55.2 0.0 52.3 2.8 53.8 1.3
12 57.8 4.0 56.7 0.0 57.3 2.1
2010 01 64.7 0.0 59.6 0.0 62.3 0.0
02 60.2 4.4 59.4 0.0 59.9 2.3
03 55.0 0.0 58.6 0.0 56.8 0.0
04 53.5 0.0 56.7 0.0 55.0 0.0
05 55.5 4.3 53.0 0.0 54.3 2.3
Beforeb Mean 62.6 2.5 52.2 0.8 57.6 1.8
Median 61.8 2.1 52.4 0.0 56.3 1.2
Afterc Mean 57.8 2.1 57.3 0.0 57.6 1.1
Median 56.7 2.0 57.7 0.0 57.1 1.1
a Educational programs arranged in November 2009.
b Before intervention: December 2008 to October 2009.
c After intervention: December 2009 to May 2010.
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significant change in the utilization ratios (Table 2).
The overall median rates of CRBSI before and after
interventions were 1.2 (mean 1.8) and 1.1 (mean 1.1)
infections per 1000 catheter-days (Table 1). The median
infection rate decreased from 1.95 (mean 1.58) infections
per 1000 catheter-days at baseline to 0 (mean 1.06) after
interventions (pZ 0.310, nZ 12). Individually, the median
rates of CRBSI in ICU1 and ICU2 showed no significant
change (ICU1: 2.14 [mean 2.34] infections per 1000
catheter-days at baseline and 2.02 [mean 2.11] after
interventions [p Z 0.893, n Z 6]; ICU2: 0 [mean 0.82]
infections per 1000 catheter-days at baseline and 0 [mean
0] after interventions [p Z 0.180, n Z 6]) (Table 3). The
rate of CRBSI in ICU2 was 0 infections per 1000 catheter-
days, which was sustained for 6 months after interven-
tions (Table 1, Fig. 2). The Poisson regression analysis shows
the relative risk of CRBSI in ICU2 is 0 (relative riskZ 0.000,
95% confidence interval Z 0.000e0.000, p Z 0.000) after
interventions (Table 4).Discussion
The CRBSI rate in this hospital before intervention (mean
1.8 per 1000 catheter-days) was higher than the 50th
percentile (1.0 per 1000 catheter-days) reported by the
NHSN.4 After interventions, the overall mean infection
rates was still higher at 1.1 per 1000 catheter-days and than
the NHSN report 50th percentile. However, the Poisson
regression analysis showed that the relative risk of CRBSI in
ICU2 was 0 after interventions. In addition, the infection
rate remained at 0 per 1000 catheter-days for 6 months in
ICU2. We believe that these simple interventions can
reduce the risk for serious catheter-related infection9; our
modified standard process of CVC implantation could
reduce the rates of CRBSI.
The TNIS report in 2009 distinguished between medical
center and regional hospital, and showed that the 50th
percentiles were 5.8 per 1000 catheter-days in medical
centers, and 3.7 in regional hospitals.5 The report showed
Figure 1. The utilization ratios of central venous catheter in ICU1, ICU2, and overall.
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whether in a medical center or regional hospital. Our CRBSI
rate is higher than the NHSN report but lower than the TNIS
report. However, as CRBSIs are associated with high
morbidity and mortality, zero tolerance may be the
nonnegotiable objective.12
The five evidence-based recommendations to reduce
CRBSI are hand washing, using full barrier precautions,
cleaning the skin with chlorhexidine, avoiding the femoral
site when possible, and removing unnecessary catheters.9 A
collaborative cohort study in Michigan, USA, which used
these recommendations, reported that the CRBSI rates
decreased from a mean of 7.7 and median of 2.7 per 1000
catheter days at baseline to 1.3 and 0, respectively, at 16 to
18 months after implementation. They remained at 1.1
and 0 at Months 34 to 36 (e1% vs. 18 months, 95% CI e9%
to þ7%).8Figure 2. The rates of catheter-related bloodIn our hospital, two of the five recommendations, hand
washing using a chlorhexidine-based product and using full
barrier precautions, were easy to accomplish as they had
been generally promoted in our operating theater. Our
surgeons assisted the educational programs in November
2009 to the staff in medical ICUs, including attending
physicans, chief residents, and nurse practitioners. In
addition, the chief residents in ICU educated new staff
before they started ICU training.
However, the next two recommendations, cleaning the
skin with chlorhexidine and avoiding the femoral site when
possible, could not be introduced when the study began.
The skin antiseptic agent with chlorhexidine was not
approved in Taiwan at that time, and the catheter site
selection (avoiding the femoral site) should be determined
by clinical physicians. The evidence for avoiding femoral
catheters is based on the higher risk for deep venousstream infection in ICU1, ICU2, and overall.
Table 2 The utilization ratios of central venous catheter from baseline to 6 months of follow-up
Ward Overall (n Z 12)
ICU1 (n Z 6) ICU2 (n Z 6)
Mean SD Median Min Max p-value Mean SD Median Min Max p-value Mean SD Median Min Max p-valuea
Before interventionb 58.09 5.22 56.89 51.77 65.42 0.917 56.26 3.86 55.42 52.51 62.97 0.753 57.18 4.48 56.64 51.77 65.42 0.875
After interventionc 57.78 4.13 56.63 53.48 64.71 57.33 2.49 57.69 52.96 59.57 57.56 3.26 57.26 52.96 64.71
a p-value by Wilcoxon Signed Ranks Test.
b Before intervention: December 2008 to May 2009.
c After intervention: December 2009 to May 2010.
Table 3 Rates of catheter-related bloodstream infection from baseline to 6 months of follow-up
Ward Overall (n Z 12)
ICU1 (n Z 6) ICU2 (n Z 6)
Mean SD Median Min Max p-value Mean SD Median Min Max p-value Mean SD Median Min Max p-valuea
Before interventionb 2.34 1.49 2.14 0.00 4.20 0.893 0.82 1.27 0.00 0.00 2.48 0.180 1.58 1.54 1.95 0.00 4.20 0.310
After interventionc 2.11 2.31 2.02 0.00 4.36 0.00 0.00 0.00 0.00 0.00 1.06 1.91 0.00 0.00 4.36
a p-value by Wilcoxon signed ranks test.
b Before intervention: December 2008 to May 2009.
c After intervention: December 2009 to May 2010.
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Table 4 Poisson regression analysis of catheter-related
bloodstream infection rates
Parameter RR 95% CI p-value
Intercept 0.001 0.001-0.002 0.000
After interventions 0.878 0.384-2.008 0.758
Before interventions 1.000
ICU2 0.324 0.095-1.108 0.072
ICU1 1.000
After interventions  ICU2 0.000 0.000-0.000 0.000
After interventions  ICU1 1.000
Before interventions  ICU2 1.000
Before interventions  ICU1 1.000
RR Z relative risk; CI Z confidence interval.
Catheter-related bloodstream infection 375thrombosis and higher colonization rates, which suggests
that such catheters are more likely to get infection.13,14 No
randomized trials have compared the risk for infection
associated with catheter insertion into jugular, subclavian,
or femoral sites, but an epidemiologic, prospective,
observational study revealed that the incidence of CVC
infection in an intensive care unit population is not
different at all three sites.15 It is difficult to convince
clinical physicians to comply with this recommendation.
Another important issue is the utilization ratios of CVCs.
The NHSN report showed that the 50th and 90th percentiles
of mean CVC utilization ratio in medical ICUs were 44% and
69%.4 Our study showed the mean overall median utilization
ratio of CVC was 57.6% before interventions were intro-
duced, and remained at this level after (Table 2). Higher
utilization ratios may be due to poor adherence to the
recommendation to remove unnecessary catheters.
It is difficult to interpret the better outcome in ICU2
after intervention. The patient source was different
between ICU1 and ICU2 (8 coronary care unit beds of the 26
in ICU2), which may explain the relative lower utilization
ratios and CRBSI rate in ICU2 before intervention, and lower
CRBSI rate after intervention. However, the utilization
ratios were not different between ICU1 and ICU2 after
intervention because the utilization ratio in ICU1 had
a downward trend. The Hawthorne effect may be the other
reason for the CRBSI rate and utilization ratio tending to
decrease in ICU1 (Fig. 1), although the change was not
significant.
Our study has several limitations. First, all data are from
a single-center and may be not extrapolate to other
centers. However, several large scale studies have sup-
ported the finding that evidence-based interventions can
reduce the rate of CRBSI.1,4,7,9 Second, we lacked the
assessments for staff adherence. The Greater Cincinnati
Health Council successfully reduced CRBSI by using
a checklist and standardizing insertion of central lines.16
The checklist is necessary to confirm the accuracy of CVC
implantation. Third, the duration of follow-up is short. A
relatively short period of the surveillance was analyzed to
determine the outcomes of our interventions. Other inter-
ventions were introduced gradually into our hospital after
this study period. The short follow-up duration may be the
reason for change after interventions being nonsignificant.
However, Poisson regression analysis showed that the
relative risk of CRBSI in ICU2 reduced.The use of maximal sterile barrier precautions in
reducing the risk of CRBSI has been documented.6 In addi-
tion, the relative risk of CRBSI in ICU2 was 0 after inter-
ventions, and the infection rates sustained 0 per 1000
catheter-days for 6 months in ICU2. We believe our modi-
fied standard procedure of CVC implantation could reduce
the rates of CRBSI. We conclude the reduction of infection
rates could be possible by our modified standard process of
CVC implantation, which included the first two recom-
mendations to reduce CRBSI. However, more interventions,
such as cleaning the skin with chlorhexidine, avoiding the
femoral site when possible, and removing unnecessary
catheters, should be considered to reduce the incidence of
CRBSI further. In addition, quality assurance by checklist
and continuing education are also necessary.References
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